Michael Alpert, M.D., is a board-certified psychiatrist and faculty member at Harvard Medical School who brings a distinctive integration of psychoanalytic training, cross-cultural psychiatric expertise, and psychedelic medicine experience to his clinical practice in Cambridge, Massachusetts. He earned his B.A. in Chinese at Yale University and his medical degree at Yale School of Medicine, completing his psychiatry residency at the Cambridge Health Alliance-Harvard Medical School program. Dr. Alpert holds a fellowship in psychoanalytic psychotherapy from the Boston Psychoanalytic Society and Institute, positioning him among a small cohort of psychiatrists who combine formal psychoanalytic depth training with active engagement in psychedelic-assisted therapy. He is a study physician, therapist, and sub-investigator on clinical trials of MDMA-assisted psychotherapy for PTSD conducted by the Multidisciplinary Association for Psychedelic Studies, and maintains an active private practice offering ketamine-assisted psychotherapy alongside psychedelic preparation and integration services. Dr. Alpert is fluent in English, Spanish, and Mandarin, and his clinical background includes community health work with Asian immigrant populations and pro-bono asylum evaluations, reflecting a commitment to social justice that infuses his therapeutic approach. He accepts Aetna and Blue Cross insurance, a rarity among psychiatrists offering psychedelic-informed care. His practice represents a thoughtful convergence of psychoanalytic sophistication, multicultural competence, and evidence-based psychedelic intervention.